The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant talazoparib in patients with germline BRCA1/2 (gBRCA1/2) mutation-positive, early HER2-negative breast cancer (BC): Results of a phase 2 study.
 
Jennifer Keating Litton
Honoraria - UpToDate
Consulting or Advisory Role - AstraZeneca; Ayala Pharmaceuticals; Medivation/Pfizer; Pfizer
Speakers' Bureau - Clinical Care Options; Med Learning Group; Medpage; Medscape; Physicans' Education Resource; Prime Oncology; UpToDate
Research Funding - AstraZeneca (Inst); EMD Serono (Inst); Genentech (Inst); pfizer (Inst); Zenith Epigenetics (Inst)
Patents, Royalties, Other Intellectual Property - UptoDate
Travel, Accommodations, Expenses - Clinical Care Options; Med Learning Group; Medscape; Physicans' Education Resource
Other Relationship - Medivation/Pfizer
 
Joseph Thaddeus Beck
Research Funding - Abbvie; Amgen; Ascentage Pharma Group; AstraZeneca; Bayer; Boston Biomedical; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; EMD Serono; Evelo Therapeutics; G1 Therapeutics; Genentech/Roche; GlaxoSmithKline; Hutchison MediPharma; Immunomedics; Laekna Therapeutics; Lilly; Mirati Therapeutics; Nektar; Novartis; Pfizer; Polynoma; Seattle Genetics
 
Jason M. Jones
No Relationships to Disclose
 
Jay Andersen
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Athenex; Biotheranostics; Myriad Genetics; Novartis; Pfizer; Puma Biotechnology; Seattle Genetics
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; Genentech; Genomic Health; Immunomedics; Novartis; Puma Biotechnology; Seattle Genetics
 
Joanne Lorraine Blum
Honoraria - Amgen; AstraZeneca; bioTheranostics; Daiichi Sankyo/Lilly; Genomic Health; Immunomedics; Myriad Genetics; Novartis; Pfizer; Puma Biotechnology; Research to Practice
Consulting or Advisory Role - Amgen; AstraZeneca; bioTheranostics; Daiichi Sankyo/Lilly; Genomic Health; Immunomedics; Myriad Genetics; Novartis; Pfizer; Puma Biotechnology; Research to Practice
 
Lida A. Mina
No Relationships to Disclose
 
Raymond Brig
No Relationships to Disclose
 
Michael A. Danso
Honoraria - Amgen
Consulting or Advisory Role - Immunomedics; Novartis; Pfizer; Seattle Genetics
 
Yuan Yuan
Consulting or Advisory Role - BCI Pharma; Diiachi; Eisai; Genentech; Guardant Health; Immunomedics; Novartis; Pfizer
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Lilly; Eisai; Genentech; Immunomedics; Merck; Novartis; Pfizer
Research Funding - Eisai; Genentech; Merck; Novartis; Pfizer; Puma Biotechnology
Expert Testimony - Novartis
 
Antonello Abbattista
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Kay Noonan
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Jayeta Chakrabarti
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Akos Czibere
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
William Fraser Symmans
Stock and Other Ownership Interests - Delphi Diagnostics; Eiger BioPharmaceuticals; ISIS Pharmaceuticals; Nuvera Biosciences
Consulting or Advisory Role - Almac Diagnostics; Merck
Patents, Royalties, Other Intellectual Property - Intellectual property; Intellectual Property (expired)
Travel, Accommodations, Expenses - Luminex; Merck
(OPTIONAL) Uncompensated Relationships - Delphi Diagnostics
 
Melinda L. Telli
Consulting or Advisory Role - Abbvie; Aduro Biotech; Celgene; Daiichi Sankyo; G1 Therapeutics; Genentech/Roche; Immunomedics; Lilly; Merck; Natera; Pfizer
Research Funding - Abbvie (Inst); Bayer (Inst); Biothera (Inst); Calithera Biosciences (Inst); EMD Serono (Inst); Genentech (Inst); Medivation (Inst); Novartis (Inst); OncoSec (Inst); Pfizer (Inst); PharmaMar (Inst); Tesaro (Inst); Vertex (Inst)
Other Relationship - G1 Therapeutics; Pfizer (I)